Tag: Johnson & Johnson

burnout, doctors, nurses, Johnson & Johnson, care

Johnson & Johnson: Caring for Care Providers: An Innovative Way to Help Address the Growing Crisis of Doctor and Nurse Burnout

Up to 70% of nurses and nearly 55% of physicians report symptoms of burnout, which costs workplaces millions of dollars a year due to lost productivity and employee turnover and absenteeism—and impacts patient quality of care. But the CareAdvantage program is poised to help. By Kristen Mascia Originally Published by…

Johnson & Johnson: From Aha! Moment to FDA Approval: The Fascinating Story Behind a New Treatment for Bladder Cancer

We retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of the disease to patients who may benefit most. Originally Published by Johnson & Johnson. By Hallie Levine It’s the sixth most common cancer, yet treatment options formetastatic bladder cancer are limited. But now, there’s…

Janssen and MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases

Originally Published by Johnson & Johnson. The Janssen Pharmaceutical Companies of Johnson & Johnson announced a worldwide collaboration and license agreement with MeiraGTx Holdings plc (NASDAQ:MGTX), a clinical-stage gene therapy company, to develop, manufacture and commercialize its clinical stage inherited retinal disease portfolio, including leading product candidates for achromatopsia (ACHM)…